Objective: To determine the efficacy and safety of Efalex to reduce symptoms of autism and to determine the relationship between blood fatty acid status and treatment response.
- Social Responsiveness Sacle – Parent (SRS-P)– Assesses social awareness, cognition, comunication, motivation, autistic mannerisms and added scores provide a total score.
- Child Behaviour Checklist (CBCL) – Measures anxious/depressed symptoms, with-drawn/depressed symptoms, somatic problems, social problems, thought problems, attention problems, rule-breaking behaviours, agressive behaviours.
- Blood Fatty Acid Composition Ratio of AA:EPA, Ratio of Omega-3 long chain polyunsaturated fatty acids (LC-PUFAs): Total LC-PUFAs, EPA and DHA
Conclusion: Efalex can safely and effectively reduce autism symptoms